Skip to main content
SpringerLink
Log in

Effect of Recombinant Human DNase on α1-Proteinase Inhibitor Function: An Experimental Approach to the Combined Clinical Use of rhDNase and α1-PI in CF Patients

  • Published:
Lung Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Children’s Hospital, Heinrich-Heine-University, D-40001 Düsseldorf, Germany, Germany

    G. Hansen, S. Hoffjan, K. Mosler & A. Schuster

Authors
  1. G. Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Hoffjan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Mosler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Schuster
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hansen, G., Hoffjan, S., Mosler, K. et al. Effect of Recombinant Human DNase on α1-Proteinase Inhibitor Function: An Experimental Approach to the Combined Clinical Use of rhDNase and α1-PI in CF Patients. Lung 179, 185–194 (2001). https://doi.org/10.1007/s004080000060

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004080000060

Search

Navigation